Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fouad Alani
Observed name:
Fatimah Alani
Institution:
University of Illinois Chicago
Observed institution:
University of Illinois Chicago
ORCID:
0009-0003-6383-3915
Observed ORCID:
0009-0003-6383-3915
OpenAlex ID:
A5111788219
Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
·
Molecular Cancer Research
·
1
Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer
2026
·
Svetlana E. Semina
, Rosemary J. Huggins
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Supplementary Figure S4 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S3 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S9 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S10 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S1 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S2 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S5 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S5 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S2 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S11 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S10 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S6 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S8 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S9 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Data from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S4 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S3 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S7 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S6 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S8 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Table S7 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Supplementary Figure S1 from Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy–Resistant Breast Cancer
2026
·
Purab Pal
, Shweta Chitkara
, et al.
Show more works
View as search
Works count:
24
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type